Market Cap 1.25B
Revenue (ttm) 310,000.00
Net Income (ttm) -149.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -48,151.61%
Debt to Equity Ratio 0.00
Volume 10,284,041
Avg Vol 5,985,524
Day's Range N/A - N/A
Shares Out 233.78M
Stochastic %K 10%
Beta 1.59
Analysts Strong Sell
Price Target $12.12

Company Profile

AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 332 282 0507
Address:
250 West 34th Street, New York, United States
McNick
McNick Jul. 3 at 6:09 AM
$ATAI why the sudden pop ? no news right ?
0 · Reply
leLu83
leLu83 Jul. 3 at 12:49 AM
$ATAI God Bless the One and Only Sole Super Power USA 🇺🇸 Its time we reclaim our identity and remember where we came from.
3 · Reply
topstockalerts
topstockalerts Jul. 3 at 12:45 AM
$ATAI this might actually have more in it than I thought
2 · Reply
luminouslumens
luminouslumens Jul. 3 at 12:07 AM
0 · Reply
mwhite9869
mwhite9869 Jul. 2 at 10:46 PM
$ATAI Have a happy and safe Independence Day, my Atai-American friends! #250 🇺🇸
2 · Reply
BigCatNY
BigCatNY Jul. 2 at 10:04 PM
$ATAI Happy Fourth everyone!!!
0 · Reply
mwhite9869
mwhite9869 Jul. 2 at 9:13 PM
$ATAI You're welcome! I trimmed at 5.10$ to put some profits into URG. And, the process has proven successful yet again. We pop after I trimmed! 😂🤦🏼‍♂️ Un-f'ing-believable
4 · Reply
leLu83
leLu83 Jul. 2 at 8:37 PM
$ATAI THE only investment grade equity in the sector. IYKYK
0 · Reply
They_Call_Me_Tater_Salad
They_Call_Me_Tater_Salad Jul. 2 at 8:24 PM
$CMPS and $ATAI hit simultaneously in 2 minute intervals from 1:43 to 1:47 with violent, price-insensitive market order sweeps. They represented the cleanest profiles for a fund looking to deploy massive blocks into late-stage TRD pipelines. Interesting tells lay in the divergences. DFTX lagged the initial move significantly. Why? They recently closed an upsized $805M offering. That massive capital injection means float mechanics are structurally clogged with overhead supply. The market had to chew through those shares before moving up in sympathy. Meanwhile, HELP completely decoupled from the sector and flatlined. This is the risk-management filter in action. With an escalating cash burn and recent $50M underwritten dilutive offering, buy programs bypassed them. Smart money doesn’t blindly chase. They swept liquid leaders ($CMPS / $ATAI), slowly absorbed the high-supply player (DFTX)and deliberately avoided (HELP). This was simply institutional capital seeking de-risked milestones.
3 · Reply
UncleJudd
UncleJudd Jul. 2 at 7:56 PM
$ATAI Flowing....
0 · Reply
Latest News on ATAI
AtaiBeckley Transcript: AGM 2026

Jun 4, 2026, 11:00 AM EDT - 4 weeks ago

AtaiBeckley Transcript: AGM 2026


AtaiBeckley reports Q1 EPS (8c), consensus (11c)

2026-05-12T16:08:09.000Z - 7 weeks ago

AtaiBeckley reports Q1 EPS (8c), consensus (11c)


AtaiBeckley Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 7 weeks ago

AtaiBeckley Quarterly report: Q1 2026


AtaiBeckley Transcript: Needham Virtual Psychedelics Forum

Apr 27, 2026, 11:00 AM EDT - 2 months ago

AtaiBeckley Transcript: Needham Virtual Psychedelics Forum


AtaiBeckley Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

AtaiBeckley Proxy statement: Proxy filing


AtaiBeckley Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

AtaiBeckley Proxy statement: Proxy filing


AtaiBeckley price target raised to $15 from $14 at Canaccord

2026-04-20T13:22:59.000Z - 2 months ago

AtaiBeckley price target raised to $15 from $14 at Canaccord


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 2 months ago

Psychedelic stocks rally with Trump's support

CMPS DFTX GHRS


AtaiBeckley price target raised to $16 from $11 at Guggenheim

2026-04-17T12:28:41.000Z - 2 months ago

AtaiBeckley price target raised to $16 from $11 at Guggenheim


AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-27T08:55:15.000Z - 3 months ago

AtaiBeckley initiated with a Buy at Deutsche Bank


AtaiBeckley initiated with a Buy at Deutsche Bank

2026-03-26T23:25:13.000Z - 3 months ago

AtaiBeckley initiated with a Buy at Deutsche Bank


AtaiBeckley Earnings release: Q4 2025

Mar 6, 2026, 12:30 PM EST - 4 months ago

AtaiBeckley Earnings release: Q4 2025


AtaiBeckley Annual report: Q4 2025

Mar 6, 2026, 12:30 PM EST - 4 months ago

AtaiBeckley Annual report: Q4 2025


AtaiBeckley Transcript: Investor Day 2026

Mar 6, 2026, 9:00 AM EST - 4 months ago

AtaiBeckley Transcript: Investor Day 2026


AtaiBeckley Slides: FY 2026

Mar 6, 2026, 9:00 AM EST - 4 months ago

AtaiBeckley Slides: FY 2026


AtaiBeckley Transcript: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Transcript: Study result


AtaiBeckley Press release: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Press release: Study result


AtaiBeckley Slides: Study result

Feb 26, 2026, 8:00 AM EST - 4 months ago

AtaiBeckley Slides: Study result


AtaiBeckley To Host Virtual Investor Day on March 6, 2026

Feb 20, 2026, 7:00 AM EST - 4 months ago

AtaiBeckley To Host Virtual Investor Day on March 6, 2026


AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Dec 23, 2025, 7:00 AM EST - 6 months ago

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)


AtaiBeckley Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

AtaiBeckley Quarterly report: Q3 2025


AtaiBeckley Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

AtaiBeckley Earnings release: Q3 2025


AtaiBeckley Transcript: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Transcript: Study Result


AtaiBeckley Press release: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Press release: Study Result


AtaiBeckley Slides: Study Result

Nov 10, 2025, 8:00 AM EST - 8 months ago

AtaiBeckley Slides: Study Result


AtaiBeckley Proxy statement: Proxy Filing

Oct 16, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Sep 29, 2025, 8:00 AM EDT - 9 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Sep 24, 2025, 8:00 AM EDT - 10 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Sep 23, 2025, 8:00 AM EDT - 10 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Transcript: Cantor Global Healthcare Conference 2025

Sep 5, 2025, 8:35 AM EDT - 10 months ago

AtaiBeckley Transcript: Cantor Global Healthcare Conference 2025


AtaiBeckley Proxy statement: Proxy Filing

Aug 14, 2025, 8:00 AM EDT - 11 months ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

AtaiBeckley Earnings release: Q2 2025


AtaiBeckley Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

AtaiBeckley Quarterly report: Q2 2025


AtaiBeckley Slides: Corporate Presentation

Jul 2, 2025, 8:30 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation


AtaiBeckley Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Transcript: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Transcript: Study Update


AtaiBeckley Press release: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Press release: Study Update


AtaiBeckley Slides: Study Update

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Slides: Study Update


AtaiBeckley Proxy statement: Proxy Filing

Jul 1, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Jun 3, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Transcript: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Transcript: M&A Announcement


AtaiBeckley Press release: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Press release: M&A Announcement


AtaiBeckley Slides: M&A Announcement

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Slides: M&A Announcement


AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Quarterly report: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Quarterly report: Q1 2025


AtaiBeckley Earnings release: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Earnings release: Q1 2025


AtaiBeckley Slides: Corporate Presentation

May 14, 2025, 7:00 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation


AtaiBeckley Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Proxy statement: Proxy Filing


AtaiBeckley Annual report: Q4 2024

Mar 17, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Annual report: Q4 2024


AtaiBeckley Earnings release: Q4 2024

Mar 17, 2025, 8:00 AM EDT - 1 year ago

AtaiBeckley Earnings release: Q4 2024


AtaiBeckley Quarterly report: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

AtaiBeckley Quarterly report: Q3 2024


AtaiBeckley Earnings release: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

AtaiBeckley Earnings release: Q3 2024


AtaiBeckley Slides: Corporate Presentation

Sep 10, 2024, 7:00 AM EDT - 1 year ago

AtaiBeckley Slides: Corporate Presentation


AtaiBeckley Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

AtaiBeckley Quarterly report: Q2 2024


AtaiBeckley Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

AtaiBeckley Earnings release: Q2 2024


McNick
McNick Jul. 3 at 6:09 AM
$ATAI why the sudden pop ? no news right ?
0 · Reply
leLu83
leLu83 Jul. 3 at 12:49 AM
$ATAI God Bless the One and Only Sole Super Power USA 🇺🇸 Its time we reclaim our identity and remember where we came from.
3 · Reply
topstockalerts
topstockalerts Jul. 3 at 12:45 AM
$ATAI this might actually have more in it than I thought
2 · Reply
luminouslumens
luminouslumens Jul. 3 at 12:07 AM
0 · Reply
mwhite9869
mwhite9869 Jul. 2 at 10:46 PM
$ATAI Have a happy and safe Independence Day, my Atai-American friends! #250 🇺🇸
2 · Reply
BigCatNY
BigCatNY Jul. 2 at 10:04 PM
$ATAI Happy Fourth everyone!!!
0 · Reply
mwhite9869
mwhite9869 Jul. 2 at 9:13 PM
$ATAI You're welcome! I trimmed at 5.10$ to put some profits into URG. And, the process has proven successful yet again. We pop after I trimmed! 😂🤦🏼‍♂️ Un-f'ing-believable
4 · Reply
leLu83
leLu83 Jul. 2 at 8:37 PM
$ATAI THE only investment grade equity in the sector. IYKYK
0 · Reply
They_Call_Me_Tater_Salad
They_Call_Me_Tater_Salad Jul. 2 at 8:24 PM
$CMPS and $ATAI hit simultaneously in 2 minute intervals from 1:43 to 1:47 with violent, price-insensitive market order sweeps. They represented the cleanest profiles for a fund looking to deploy massive blocks into late-stage TRD pipelines. Interesting tells lay in the divergences. DFTX lagged the initial move significantly. Why? They recently closed an upsized $805M offering. That massive capital injection means float mechanics are structurally clogged with overhead supply. The market had to chew through those shares before moving up in sympathy. Meanwhile, HELP completely decoupled from the sector and flatlined. This is the risk-management filter in action. With an escalating cash burn and recent $50M underwritten dilutive offering, buy programs bypassed them. Smart money doesn’t blindly chase. They swept liquid leaders ($CMPS / $ATAI), slowly absorbed the high-supply player (DFTX)and deliberately avoided (HELP). This was simply institutional capital seeking de-risked milestones.
3 · Reply
UncleJudd
UncleJudd Jul. 2 at 7:56 PM
$ATAI Flowing....
0 · Reply
stoxx0007
stoxx0007 Jul. 2 at 7:53 PM
$ATAI .... WHO DID THAT!!!???? with that Huge BUY??? 🤔🤔 ...
1 · Reply
Hanaleimike
Hanaleimike Jul. 2 at 7:26 PM
$ATAI fucking games. Please everyone tell me how this stock in not manipulated af
1 · Reply
GeorgeJetson17
GeorgeJetson17 Jul. 2 at 6:32 PM
$ATAI Damn, I was so close to buying more at $4.80 too. 😂
2 · Reply
Psychedelic_Stonks
Psychedelic_Stonks Jul. 2 at 6:01 PM
$ATAI above $5 feels so cozy 🥰
0 · Reply
jmash
jmash Jul. 2 at 5:54 PM
$ATAI $CMPS $DFTX does explain the pop?
1 · Reply
matrixtrade123
matrixtrade123 Jul. 2 at 5:49 PM
$ATAI anyone hearing about a Big Pharma partnership?
0 · Reply
Tradebub
Tradebub Jul. 2 at 5:48 PM
0 · Reply
annee33
annee33 Jul. 2 at 5:48 PM
$ATAI Volume Alert!
0 · Reply
stoxx0007
stoxx0007 Jul. 2 at 4:36 PM
0 · Reply
twiggs462
twiggs462 Jul. 2 at 4:20 PM
$DFTX $ATAI $CMPS Bipartisan Congressional Bill Would Codify Trump’s Psychedelics Order Into Law https://www.marijuanamoment.net/bipartisan-congressional-bill-would-codify-trumps-psychedelics-order-into-law/ H.R.9559 - To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes. https://www.congress.gov/bill/119th-congress/house-bill/9559 Helps with DEA rescheduling visibility, manufacturing quotas, controlled distribution, clinical site expansion, VA-related treatment pathways, and broader institutional comfort around psychedelic medicine. This is also the kind of policy shift that big pharma pays attention to. A late-stage drug with strong data is one thing. A late-stage drug with improving federal policy, potential priority voucher support, and clearer post-approval scheduling rules is much easier to underwrite. Bullish for the whole sector.
1 · Reply
duhbledown11
duhbledown11 Jul. 2 at 2:47 PM
$ATAI sorry fellas I held when it was above $5 instead of selling. That’s why we’re dropping lol 😆
0 · Reply
Supersecret
Supersecret Jul. 2 at 11:25 AM
$ATAI In a buyer @ 4.28 but not sure we ever see that again
1 · Reply